Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The RIVET RCT: Rifamycin SV MMX improves muscle mass, physical function, and ammonia in cirrhosis and minimal encephalopathy
Jasmohan S. Bajaj, Andrew Fagan, Edith Gavis, et al.
Hepatology Communications (2024) Vol. 8, Iss. 2
Open Access | Times Cited: 10

Showing 10 citing articles:

Attenuating hyperammonemia preserves protein synthesis and muscle mass via restoration of perturbed metabolic pathways in bile duct-ligated rats
Cristina R. Bosoi, Avinash Kumar, M. Oliveira, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 1
Closed Access | Times Cited: 1
A Systematic Review of Microbiota in Cirrhosis: A Change Towards a More Pathogenic Predisposition
Elias Xirouchakis, Alexandros Pelekanos, Spyridon Xirouchakis, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 527-527
Open Access
Microbial Approaches to Treat and Prevent Hepatic Encephalopathy
Mette Munk Lauridsen, Elise Jonasson Nielsen, Jasmohan S. Bajaj
Gastroenterology Clinics of North America (2025) Vol. 54, Iss. 2, pp. 429-451
Closed Access
Chinese Guidelines on the Management of Hepatic Encephalopathy in Cirrhosis (2024)
Xiaoyuan Xu, Huiguo Ding, Wengang Li, et al.
Journal of Clinical and Translational Hepatology (2025) Vol. 000, Iss. 000, pp. 000-000
Open Access
Rifaximin-α use is associated with improved muscle mass in patients with cirrhosis
Thomas Worland, Penelope Hey, Darren Wong, et al.
World Journal of Hepatology (2025) Vol. 17, Iss. 4
Closed Access
Genome Mining Reveals Rifamycin Biosynthesis in a Taklamakan Desert Actinomycete
Xinrong Luo, Zhanwen Liu, Xiaoxia Luo, et al.
Microorganisms (2025) Vol. 13, Iss. 5, pp. 1068-1068
Open Access
Fecal microbiota transplantation in the treatment of hepatic encephalopathy: A perspective
Arghya Samanta, Moinak Sen Sarma
World Journal of Hepatology (2024) Vol. 16, Iss. 5, pp. 678-683
Open Access
Let’s Pump You Up!
Stephanie Y. Tsai, Jacqueline G. O’Leary
Hepatology (2024)
Open Access
Letter to the Editor: Rifamycin SV MMX was superior to placebo, but was the comparison appropriate?
Meng Zhu, Zhangcheng Wang, Xiangfeng Tian, et al.
Hepatology Communications (2024) Vol. 8, Iss. 8
Open Access
Hepatic encephalopathy: experimental drugs in development and therapeutic potential
Antonio Gil‐Gómez, Rocío Múñoz‐Hernández, Filomeno Martínez, et al.
Expert Opinion on Investigational Drugs (2024), pp. 1-12
Closed Access
Page 1

Scroll to top